Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Profit After Tax (2016 - 2025)

Historic Profit After Tax for BioCorRx (BICX) over the last 17 years, with Q3 2025 value amounting to -$1.9 million.

  • BioCorRx's Profit After Tax fell 2675.88% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.4 million, marking a year-over-year decrease of 850.05%. This contributed to the annual value of -$5.2 million for FY2024, which is 3823.41% down from last year.
  • BioCorRx's Profit After Tax amounted to -$1.9 million in Q3 2025, which was down 2675.88% from -$1.4 million recorded in Q2 2025.
  • BioCorRx's Profit After Tax's 5-year high stood at -$851764.0 during Q1 2025, with a 5-year trough of -$1.9 million in Q3 2025.
  • Its 5-year average for Profit After Tax is -$1.2 million, with a median of -$1.2 million in 2021.
  • Its Profit After Tax has fluctuated over the past 5 years, first soared by 4034.38% in 2022, then crashed by 7444.09% in 2024.
  • Over the past 5 years, BioCorRx's Profit After Tax (Quarter) stood at -$1.2 million in 2021, then grew by 3.2% to -$1.2 million in 2022, then increased by 16.68% to -$969009.0 in 2023, then decreased by 26.69% to -$1.2 million in 2024, then crashed by 56.23% to -$1.9 million in 2025.
  • Its last three reported values are -$1.9 million in Q3 2025, -$1.4 million for Q2 2025, and -$851764.0 during Q1 2025.